AKR1B1 and Hyperglycemia: Urinary levels of platelet thromboxane (TX) metabolites are elevated in patients with T2DM [125], and it was demonstrated that aldose reductase is an important enzyme that mediates hyperglycemia and collagen-induced platelet activation and TX release through a pathway involving ROS generation [126].